List of SBIR/STTR awards granted to Xeris Pharmaceuticals, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Xeris Pharmaceuticals, Inc. in July, 2016 for $1,221,086.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44DK107114-02 | Phase II | 1,221,086 | July 10, 2016 | |||||||
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. in July, 2015 for $561,530.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK107114-01 | Phase I | 561,530 | July 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Xeris Pharmaceuticals, Inc. in September, 2017 for $1,591,098.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44NS086229-02 | Phase II | 1,591,098 | September 15, 2017 | |||||||
A SBIR Phase II contract was awarded to Xeris Pharmaceuticals, Inc. in September, 2016 for $1,587,798.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44DK105691-02 | Phase II | 1,587,798 | September 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. in September, 2015 for $514,129.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44NS086229-01A1 | Phase I | 514,129 | September 30, 2015 | |||||||
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. in April, 2015 for $485,403.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK105691-01 | Phase I | 485,403 | April 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. for $678,969.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK096715-01A1 | Phase I | 678,969 | ||||||||
A SBIR Phase II contract was awarded to Xeris Pharmaceuticals, Inc. for $451,756.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44DK096715-02 | Phase II | 451,756 | ||||||||
A SBIR Phase II contract was awarded to Xeris Pharmaceuticals, Inc. for $994,123.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK085809-02 | Phase II | 994,123 | ||||||||
A SBIR Phase II contract was awarded to Xeris Pharmaceuticals, Inc. for $713,733.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44DK096706-02 | Phase II | 713,733 | ||||||||
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. for $343,124.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK096706-01 | Phase I | 343,124 | ||||||||
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. for $157,478.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK085809-01 | Phase I | 157,478 |
